CD8A and neoplasm: In addition, patients with 9p21 WT had significantly higher levels of aDCs, B cells, CD8+ T cells, cytolytic activity, HLA, inflammation-promoting factors, neutrophils, T-cell co-stimulation, Tfh, Th1 cells, and tumour-infiltrating lymphocyte (TIL) than patients with 9p21 loss.